Leukoencephalopathy, Progressive Multifocal D007968

Related MeSH Hierarchy (11)

Diseases [C] » Nervous System Diseases [C10] » Demyelinating Diseases » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Central Nervous System Infections » Infectious Encephalitis » Encephalitis, Viral » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Nervous System Diseases [C10] » Neuroinflammatory Diseases » Encephalitis » Infectious Encephalitis » Encephalitis, Viral » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Infections [C01] » Central Nervous System Infections » Central Nervous System Viral Diseases » Encephalitis, Viral » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Infections [C01] » Central Nervous System Infections » Infectious Encephalitis » Encephalitis, Viral » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Infections [C01] » Virus Diseases » Central Nervous System Viral Diseases » Encephalitis, Viral » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Polyomavirus Infections » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Infections [C01] » Virus Diseases » Slow Virus Diseases » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Encephalitis » Infectious Encephalitis » Encephalitis, Viral » Leukoencephalopathy, Progressive Multifocal

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Leukoencephalopathies » Leukoencephalopathy, Progressive Multifocal

Description

An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)   MeSH

Approved Indicated Drugs (1)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 1 Indications (1)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.